Form 4: Verastem Director Michelle Robertson Executes Option Exchange Program

Michelle Robertson, a director at Verastem, Inc., participated in the company's option exchange program, resulting in the cancellation of existing stock options and the grant of new ones.

Summary

• On March 11, 2024, Michelle Robertson, a director of Verastem, Inc., participated in the company's option exchange program.
• As part of this program, certain unexercised stock options with an exercise price greater than $15.00 were cancelled.
• In exchange, Ms. Robertson received a grant of 5,291 new stock options with an exercise price of $11.44.
• These new options will vest in two equal installments over a two-year period from March 11, 2024, contingent on continued service as a director or service provider to the Issuer.
• The cancelled stock options were originally granted on November 15, 2021, and vested in twelve equal monthly installments.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (option exchange) for a company director. It's neither overwhelmingly positive nor negative, but suggests an effort to maintain director incentives.

Positives

• The option exchange program may incentivize continued service from the director.
• The new options have a lower exercise price ($11.44) than the cancelled options (over $15.00), potentially increasing their value to the director.

Future Outlook

The new stock options will vest in two equal installments over a two-year period from March 11, 2024, provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Industry Context

Option exchange programs are sometimes used by companies to refresh employee or director incentives, particularly when the stock price has fallen below the exercise price of existing options. This can help retain talent and align their interests with shareholders.

Stakeholder Impact

• Shareholders may view the option exchange program as a way to align director interests with the company's performance.
• The director benefits from the new options with a lower exercise price.

Key Dates